Psyched Wellness Ltd. announced the preliminary data revealing a potential new functional property and health benefit of AME-1. Preliminary data that has been generated in tests done by the National Research Council of Canada (NRC) shows that AME-1 extract can inhibit human connective-tissue mast cell activation. Mast cells are important inflammatory cells present in skin, gut, brain, and lungs. When activated, these cells release proinflammatory mediators such as histamine and cytokines, contributing to inflammatory diseases such as atopic dermatitis and urticaria, also known as hives, in the skin. The results of the studies show that pre-treatment of human mast cells with AME-1 extract inhibited their activation and partially blocked the release of proinflammatory mediators. This preliminary evidence suggests a potential key nutritional systematic and functional property of AME-1, with research continuing to further examine the mechanisms of this inhibition. The NRC specializes in providing vital scientific and technological services to the research and industrial communities of Canada and was hired by Psyched Wellness to provide expertise in biomedical nanotechnology. The results of the research belong to Psyched, and the NRC does not endorse the findings or Psyched products.